You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國生物科技服務(08037.HK)附屬擬購買硼中子治療設備部件及採購硼中子治療設備維護服務

格隆匯1月17日丨中國生物科技服務(08037.HK)公吿,於2023年1月17日,公司、鵬博海南(公司間接非全資附屬公司)與SHI訂立銷售合約,據此,鵬博海南同意購買而SHI同意出售硼中子治療設備部件,初步銷售合約價為4.36億日圓(不包括鵬博海南可能需承擔的任何預扣税及可予調整事項金額)。

於2023年1月17日,公司、鵬博海南與SHI訂立維護服務合約,據此,鵬博海南同意採購而SHI同意提供有關硼中子治療設備的維護服務,代價為3.6億日圓(不包括鵬博海南可能需承擔的任何預扣税)。

SHI是一家在日本註冊成立的公司,主要從事重型電力機械的製造及銷售業務,其已發行股份在東京證券交易所上市(股票代號:6302)。SHI經營(當中包括)機械電子、工業機械、工業設備、物流及建築以及能源及生命線部門。SHI亦生產半導體及激光技術設備。作為SHI工業設備部門的一部分,SHI一直參與科學、工業及醫學領域,其醫療設備包括硼中子治療設備及其他早期癌症檢測及癌症治療設備。

集團正在海南建設該中心以進行硼中子癌症治療。銷售合約及維護服務合約是該等先前交易的一個組成部分,為該中心開始運營及維護所必需的。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account